McSweeney / Langevin Providing Legal Advice in Response to Alleged Levaquin-Related Retinal Detachment, Vision Loss and Other Levaquin-Related Eye Injuries

Share Article

The law firm McSweeney / Langevin is investigating retinal detachment claims allegedly caused by Levaquin. McSweeney / Langevin's legal investigation follows the Food and Drug Administration's recent warning concerning peripheral neuropathy.

We are providing free legal consultations to people suffering from injuries due to Levaquin in an effort to provide a resolution to the damage that has been done

With over 1,800 cases comprising the Multidistrict Litigation (MDL 08-MD-1943) against the Johnson & Johnson and Ortho-McNeil manufactured antibiotic Levaquin (levofloxacin), Minneapolis-based law firm McSweeney / Langevin and its Levaquin lawyers are offering free legal consultations to individuals injured as a result of Levaquin and other drugs in the fluoroquinolone antibacterial family of drugs.

Antibacterial fluoroquinolone drugs have been linked to serious tendon injuries and tendon ruptures, permanent nerve damage and a severe skin disorder known as Stevens-Johnson Syndrome. The FDA warned of these risks several years ago. However, the FDA warning concerning peripheral neuropathy is new, and applies to fluoroquinolones that are taken by mouth or by injection. Approved fluoroquinolone drugs include levofloxacin (Levaquin), ciprofloxacin (Cipro), moxifloxacin (Avelox), norfloxacin (Noroxin), ofloxacin (Floxin) and gemifloxacin (Factive). The topical formulations of fluoroquinolones, applied to the ears or eyes, are not known to be associated with this risk.

As a result of this new warning McSweeney / Langevin has begun to investigate potential Levaquin-related claims involving retinal detachment, vision loss, and other eye injuries.

“We have dedicated a tremendous amount of resources to Levaquin-related claims due to the extraordinary injuries individuals have allegedly sustained from Levaquin and other drugs in its class,” said David Langevin, founding partner of McSweeney / Langevin. “We are providing free legal consultations to people suffering from injuries due to Levaquin in an effort to provide a resolution to the damage that has been done.”

The Food and Drug Administration (FDA) is also paying attention, announcing on Aug. 15 that it will be requiring label changes for all fluoroquinolone antibacterial drugs to “better describe the serious side effect of peripheral neuropathy,” which is the serious nerve damage plaintiffs have been experiencing.

For more information on Levaquin and how McSweeney / Langevin can help, visit http://westrikeback.com/practice-areas/dangerous-defective-drugs/levaquin/ or call     1-800-888-4425 to be connected with an attorney.

About McSweeney / Langevin

With the sole purpose of helping the injured, the personal injury law firm McSweeney / Langevin ensures accident victims and victims’ families are adequately compensated for wage loss, medical expenses and pain and suffering. While most firms have you speak with an “investigator” or “case manager,” McSweeney / Langevin connects people directly with attorneys who will be handling your case. The firm handles personal injury cases related to dangerous/defective pharmaceutical drugs, dangerous/defective medical devices, and serious/catastrophic injury claims. For more information, visit http://www.westrikeback.com or call 1-800-888-4425.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Langevin

Rhett McSweeney
Visit website